ArticleCell death discovery2022

The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.

Sandra Weller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.